Baker Brothers Advisors - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2021$4,611,000
-70.4%
4,500,000
-70.0%
0.02%
-70.6%
Q2 2021$15,566,000
+1.7%
15,000,0000.0%0.07%
+3.0%
Q1 2021$15,299,000
-4.6%
15,000,0000.0%0.07%
+10.0%
Q4 2020$16,033,000
+2.4%
15,000,0000.0%0.06%
-4.8%
Q3 2020$15,650,000
-14.7%
15,000,0000.0%0.06%
-22.2%
Q2 2020$18,340,000
+17.7%
15,000,0000.0%0.08%
-15.6%
Q1 2020$15,576,000
-1.7%
15,000,0000.0%0.10%
+14.3%
Q4 2019$15,841,000
+7.6%
15,000,0000.0%0.08%
-16.0%
Q3 2019$14,722,000
-5.4%
15,000,0000.0%0.10%
-5.7%
Q2 2019$15,566,000
+1.2%
15,000,0000.0%0.11%
+8.2%
Q1 2019$15,385,000
+3.2%
15,000,0000.0%0.10%
-19.7%
Q4 2018$14,911,000
-5.7%
15,000,0000.0%0.12%
+17.3%
Q3 2018$15,818,000
+4.1%
15,000,0000.0%0.10%
-8.8%
Q2 2018$15,198,000
+7.8%
15,000,0000.0%0.11%
-5.0%
Q1 2018$14,099,000
-5.6%
15,000,0000.0%0.12%
-7.0%
Q4 2017$14,928,000
-1.7%
15,000,0000.0%0.13%
+4.9%
Q3 2017$15,193,00015,000,0000.12%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,692,000$31,428,0002.14%
PFM Health Sciences, LP 45,910,000$48,118,0001.64%
Cheyne Capital Management (UK) LLP 2,320,000$2,442,0001.59%
ADVENT CAPITAL MANAGEMENT /DE/ 42,088,000$44,271,0000.74%
Opti Capital Management, LP 8,095,000$8,560,0000.65%
Nicholas Investment Partners, LP 8,700,000$9,097,0000.58%
SSI INVESTMENT MANAGEMENT LLC 8,944,000$9,351,0000.55%
MACKAY SHIELDS LLC 30,060,000$31,477,0000.26%
PALISADE CAPITAL MANAGEMENT, LP 11,686,000$12,292,0000.25%
BNP Paribas Asset Management Holding S.A. 4,175,000$74,141,0000.25%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders